Type 1 beta cells succumb to autoimmunity, leaving significantly reduced beta-cell mass and lifelong dependence on insulin replacement therapy, while type 2 beta cells fail to secrete sufficient insulin to overcome prevailing insulin resistance.
Read More »CGM Will Change The Way We Treat Type 1 And Type 2 Diabetes
Let’s start off with what is in the pipeline.
Read More »The Disease That May Be a Leading Cause of Death
Survey estimates that diabetes accounts for many more deaths in the United States than are being reported on death certificates — and that diabetes is actually the third leading cause of death.
Read More »Life Happens to Our Patients Too. Be Understanding.
Woman, type 1 diabetes, 63 years of age. Well-educated diabetes wise. Reached out to me saying: "HELP!! Normally I take 10 units of Toujeo at 9 pm. I did that last night. This morning I meant to take an additional 2 units because I'm not getting any exercise due to a knee injury. By mistake I took my usual dose of 10 units." Before I read the rest of her email, I thought, I know her. She knows what to do. She wears a CGM, she’ll be watching that. Then I read on...
Read More »Continuous Glucose Monitoring To Improve Diabetes Control
Two studies show use of sensor implanted under skin that continuously monitors glucose levels resulted in improved levels in T1 patients who inject insulin multiple times a day.
Read More »The Most Common Hassle For Type 1 Diabetes Patients
Barrier means more work including monitoring more often and making more adjustments.
Read More »FDA Approves First Artificial Pancreas
Device automatically monitors blood glucose levels and delivers insulin when appropriate for people age 14 years and older who have type 1 diabetes.
Read More »Reclassifying Diabetes: is it Time for an Expanded Definition?
For those healthcare providers who treat diabetes with any kind of regularity, it has become increasingly obvious that several of our patients fall outside the current diabetes classification system. With individualization of patient care being the new focus, it can be challenging to accomplish this, when certain diabetic individuals don’t “conform” to the current definitions.
Read More »Metformin in Type 1 Patients Slows Development of Heart Disease
Scientists believe drug commonly prescribed for T2 could be routinely taken by T1 patients.
Read More »Evaluating the Role of Liraglutide in Type I Diabetes
Could GLP-1 inhibitors be a useful adjunct therapy in type I diabetes?
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.